HALO · Forms 3, 4, 5
Insider trades at HALOZYME THERAPEUTICS, INC.
2 insiders sold $7.2M of HALOZYME THERAPEUTICS, INC. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for HALOZYME THERAPEUTICS, INC. (HALO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 4,810 | $108.18 | $520K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 3,090 | $108.91 | $337K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 11,900 | $110.00 | $1.3M | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 200 | $110.51 | $22K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 8,600 | $111.03 | $955K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 10,300 | $111.84 | $1.2M | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 900 | $112.78 | $102K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 200 | $113.69 | $23K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 2,300 | $107.90 | $248K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 6,000 | $109.33 | $656K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 9,920 | $109.89 | $1.1M | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 1,780 | $110.81 | $197K | Form 4 | |
| James M Daly | Director | Became an insider (Form 3) | Form 3 | ||||
| James M Daly | Director | Award | 1,169 | Form 4 | |||
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 730 | $107.17 | $78K | Form 4 | |
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 3,300 | $108.45 | $358K | Form 4 | |
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 1,100 | $109.57 | $121K | Form 4 | |
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 100 | $110.04 | $11K | Form 4 | |
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 3,100 | $106.13 | $329K | Form 4 | |
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 3,000 | $106.83 | $320K | Form 4 | |
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 8,896 | $108.04 | $961K | Form 4 | |
| Matthew L. Posard | Director | Sell (10b5-1 plan) | 4,000 | $108.99 | $436K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 15,492 | $107.15 | $1.7M | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 4,508 | $107.55 | $485K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 14,588 | $107.01 | $1.6M | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 5,412 | $107.58 | $582K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 13,304 | $107.22 | $1.4M | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 6,596 | $107.82 | $711K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 100 | $108.67 | $11K | Form 4 | |
| Dannielle Appelhans | Director | Award | 1,161 | Form 4 | |||
| Dannielle Appelhans | Director | Became an insider (Form 3) | Form 3 | ||||
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 7,200 | $106.36 | $766K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 9,600 | $107.22 | $1M | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 3,200 | $107.77 | $345K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 5,703 | $103.08 | $588K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 4,897 | $104.11 | $510K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 9,400 | $104.87 | $986K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Option exercise | 20,000 | $18.41 | $368K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 900 | $98.96 | $89K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 500 | $100.46 | $50K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 2,100 | $101.77 | $214K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 9,000 | $102.55 | $923K | Form 4 | |
| Helen Torley | PRESIDENT AND CEO | Sell (10b5-1 plan) | 7,500 | $103.48 | $776K | Form 4 | |
| Bernadette Connaughton | Director | Sell (10b5-1 plan) | 1,626 | $102.80 | $167K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.